Literature DB >> 9655246

Linear amplification mapping of polycyclic aromatic hydrocarbon-reactive sequences in H-ras gene.

D Chakravarti1, E L Cavalieri, E G Rogan.   

Abstract

Linear amplification, or primer directed single-strand DNA synthesis, is commonly used in applications such as cycle sequencing and mapping replication block sites in DNA. Although linear amplification reactions would be expected to synthesize full-length single-stranded DNA, the synthesis is often prematurely terminated. We describe the optimization of a linear amplification protocol for synthesizing a full-length (985-nt) single-stranded pBR322 segment. The enzyme activities of five DNA polymerases commonly used in PCR amplification, namely, AmpliTaq, Stoffel fragment, Tth, Pfu, and Vent, were tested either singly or in combination. The results indicate that the additive action of small amounts of proofreading DNA polymerases to a nick-translating polymerase is optimum for linear amplification. From these results, a linear amplification protocol was developed to map DNA synthesis-blocking sites generated by the reaction of (+/-) anti-benzo[a]pyrene-7,8-diol-9,10-epoxide, or anti- or syn-dibenzo[a,l]pyrene-9,10-diol-11,12-epoxide with H-ras DNA surrounding the oncogenic codon 61 region. The results indicate that the central A of H-ras codon 61 (CAA) reacts with these polycyclic aromatic hydrocarbons.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655246     DOI: 10.1089/dna.1998.17.529

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  2 in total

1.  Formation of template-switching artifacts by linear amplification.

Authors:  Dhrubajyoti Chakravarti; Paula C Mailander
Journal:  J Biomol Tech       Date:  2008-07

2.  The role of polycyclic aromatic hydrocarbon-DNA adducts in inducing mutations in mouse skin.

Authors:  Dhrubajyoti Chakravarti; Divya Venugopal; Paula C Mailander; Jane L Meza; Sheila Higginbotham; Ercole L Cavalieri; Eleanor G Rogan
Journal:  Mutat Res       Date:  2007-09-07       Impact factor: 2.433

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.